The most serious adverse effects associated with bevacizumab include hypertensive crisis, nephrotic syndrome, hemorrhage, gastrointestinal perforation, wound-healing complications, and congestive ...
The approval was based on data demonstrating that the biosimilar product and the reference product were highly similar, and that there were no clinically meaningful differences between the agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results